Part D Cost Estimate Drops To $373 Bil. Over 10 Years
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS attributes the 41 percent drop from the original $634 billion estimate in part to better-than-anticipated drug price negotiations by Part D plans and a decline in drug cost trend.